Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation
- 31 March 2011
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 60 (2-3), 373-380
- https://doi.org/10.1016/j.neuropharm.2010.10.002
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Environmental Health Sciences
- NIAAA
- The UNC Bowles Center for Alcohol Studies
- National Science Council (NSC-96-2320-B-037-039-MY3)
This publication has 37 references indexed in Scilit:
- L‐type calcium channel blockers and Parkinson disease in DenmarkAnnals of Neurology, 2010
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Contribution of Downregulation of L-type Calcium Currents to Delayed Neuronal Death in Rat Hippocampus after Global Cerebral Ischemia and ReperfusionJournal of Neuroscience, 2007
- Simultaneous measurement of superoxide generation and intracellular Ca2+ concentration reveals the effect of extracellular Ca2+ on rapid and transient contents of superoxide generation in differentiated THP-1 cellsBiochemical and Biophysical Research Communications, 2006
- Reactive microgliosis participates in MPP+‐induced dopaminergic neurodegeneration: role of 67 kDa laminin receptorThe FASEB Journal, 2006
- Chronic stimulation of GABAA receptor with muscimol reduces amyloid β protein (25–35)-induced neurotoxicity in cultured rat cortical cellsNeuroscience Research, 2005
- NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated MicrogliaJournal of Biological Chemistry, 2004
- Cytoprotective effects of calcium channel blockers: Mechanisms and potential applications in hepatocellular injuryJournal of Hepatology, 1991
- Calcium-Channel DrugsJournal of Cardiovascular Pharmacology, 1991
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985